Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:29 pm Purchase |
2024-12-31 | 13G | Intensity Therapeutics, Inc. INTS |
ARMISTICE CAPITAL LLC | 1,126,868 8.130% |
1,126,868 (New Position) |
Filing History |
| 2025-02-14 5:28 pm Purchase |
2024-12-31 | 13G | Globus Maritime Limited GLBS |
ARMISTICE CAPITAL LLC | 1,200,000 5.510% |
1,200,000 (New Position) |
Filing History |
| 2025-02-14 5:28 pm Sale |
2024-12-31 | 13G | Draganfly Inc. DPRO |
ARMISTICE CAPITAL LLC | 480,794 8.860% |
-1,114,414 (-69.86%) |
Filing History |
| 2025-02-14 5:27 pm Purchase |
2024-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
ARMISTICE CAPITAL LLC | 4,997,275 9.990% |
4,997,275 (New Position) |
Filing History |
| 2025-02-14 5:26 pm Purchase |
2024-12-31 | 13G | Bio-Path Holdings, Inc. BPTH |
ARMISTICE CAPITAL LLC | 613,798 9.990% |
613,798 (New Position) |
Filing History |
| 2025-02-14 5:25 pm Sale |
2024-12-31 | 13G | BIO-key International, Inc. BKYI |
ARMISTICE CAPITAL LLC | 164,235 4.990% |
-85,765 (-34.31%) |
Filing History |
| 2025-02-14 5:25 pm Sale |
2024-12-31 | 13G | Brainstorm Cell Therapeutics Inc. BCLI |
ARMISTICE CAPITAL LLC | 299,548 4.990% |
-7,784,398 (-96.29%) |
Filing History |
| 2025-02-14 5:24 pm Purchase |
2024-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
ARMISTICE CAPITAL LLC | 5,396,000 9.880% |
196,000 (+3.77%) |
Filing History |
| 2025-02-14 5:23 pm Purchase |
2024-12-31 | 13G | Catheter Precision, Inc. VTAK |
ARMISTICE CAPITAL LLC | 874,079 9.990% |
768,336 (+726.61%) |
Filing History |
| 2025-02-14 5:23 pm Purchase |
2024-12-31 | 13G | VolitionRx Limited VNRX |
ARMISTICE CAPITAL LLC | 9,343,265 9.990% |
119,885 (+1.30%) |
Filing History |
| 2025-02-14 5:22 pm Purchase |
2024-12-31 | 13G | Vincerx Pharma, Inc. VINC |
ARMISTICE CAPITAL LLC | 4,475,121 9.990% |
4,475,121 (New Position) |
Filing History |
| 2025-02-14 5:22 pm Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ARMISTICE CAPITAL LLC | 7,358,000 9.620% |
-290,000 (-3.79%) |
Filing History |
| 2025-02-14 5:21 pm Purchase |
2024-12-31 | 13G | Treace Medical Concepts, Inc. TMCI |
ARMISTICE CAPITAL LLC | 6,209,000 9.970% |
13,000 (+0.21%) |
Filing History |
| 2025-02-14 5:21 pm Purchase |
2024-12-31 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP |
ARMISTICE CAPITAL LLC | 95,373 9.990% |
56,121 (+142.97%) |
Filing History |
| 2025-02-14 5:20 pm Sale |
2024-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
ARMISTICE CAPITAL LLC | 4,836,000 8.760% |
-260,000 (-5.10%) |
Filing History |
| 2025-02-14 5:20 pm Purchase |
2024-12-31 | 13G | Steakholder Foods Ltd. STKH |
ARMISTICE CAPITAL LLC | 69,297 9.990% |
3,919 (+5.99%) |
Filing History |
| 2025-02-14 5:19 pm Unchanged |
2024-12-31 | 13G | Sadot Group Inc. SDOT |
ARMISTICE CAPITAL LLC | 411,523 6.560% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:19 pm Sale |
2024-12-31 | 13G | Rockwell Medical, Inc. RMTI |
ARMISTICE CAPITAL LLC | 3,249,178 9.990% |
-332,347 (-9.28%) |
Filing History |
| 2025-02-14 5:18 pm Sale |
2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
ARMISTICE CAPITAL LLC | 1,152,000 6.540% |
-384,000 (-25.00%) |
Filing History |
| 2025-02-14 5:18 pm Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
ARMISTICE CAPITAL LLC | 6,378,000 8.270% |
-856,898 (-11.84%) |
Filing History |